The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARVINAS INC | COM | 04335A105 | 18,892 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 12,884 | 1,501,591 | SH | SOLE | 1,501,591 | 0 | 0 | ||
| CYTEIR THERAPEUTICS INC | COM | 23284P103 | 3,633 | 319,538 | SH | SOLE | 319,538 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 15,798 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
| GUARDANT HEALTH INC | COM | 40131M109 | 10,502 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 5,372 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 10,165 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 7,769 | 406,986 | SH | SOLE | 406,986 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 9,196 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| ISOPLEXIS CORP | COM | 465005106 | 16,267 | 1,770,118 | SH | SOLE | 1,770,118 | 0 | 0 | ||
| JOUNCE THERAPEUTICS INC | COM | 481116101 | 4,801 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 9,534 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
| LEAP THERAPEUTICS INC | COM | 52187K101 | 5,881 | 1,815,000 | SH | SOLE | 1,815,000 | 0 | 0 | ||
| MEDAVAIL HOLDINGS INC | COM | 58406B103 | 4,089 | 2,920,780 | SH | SOLE | 2,920,780 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 482 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 12,469 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 6,346 | 1,225,060 | SH | SOLE | 1,225,060 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 7,813 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 7,686 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| NATERA INC | COM | 632307104 | 25,029 | 268,000 | SH | SOLE | 268,000 | 0 | 0 | ||
| NUVATION BIO INC | COM CL A | 67080N101 | 10,176 | 1,197,152 | SH | SOLE | 1,197,152 | 0 | 0 | ||
| REPLIGEN CORP | COM | 759916109 | 18,539 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 4,660 | 437,960 | SH | SOLE | 437,960 | 0 | 0 | ||
| SIGHT SCIENCES INC | COM | 82657M105 | 6,014 | 342,304 | SH | SOLE | 342,304 | 0 | 0 | ||
| SOMALOGIC INC | CLASS A COM | 83444K105 | 9,312 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 10,806 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 4,438 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 11,540 | 3,539,895 | SH | SOLE | 3,539,895 | 0 | 0 | ||
| VERVE THERAPEUTICS INC | COM | 92539P101 | 4,069 | 110,360 | SH | SOLE | 110,360 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 11,956 | 604,774 | SH | SOLE | 604,774 | 0 | 0 | ||